Point-of-Care Program Increases Prostate Cancer Genetic Testing
Researchers pioneered and implemented a novel algorithm to provide genetic testing to patients with newly diagnosed prostate cancer.
Read MorePosted by Andy Lundin | Dec 15, 2022 | Prostate |
Researchers pioneered and implemented a novel algorithm to provide genetic testing to patients with newly diagnosed prostate cancer.
Read MorePosted by Andy Lundin | Dec 13, 2022 | Unknown Origin & Other Cancer Types |
A new study revealed a breakthrough hand-held biosensor that enables quick and accurate detection of oral cancer.
Read MorePosted by Andy Lundin | Dec 12, 2022 | Covid 19 |
Virax Biolabs announced their supplier has received an EUA from the U.S. FDA for their over-the-counter COVID-19 rapid antigen test.
Read MorePosted by Chris Wolski | Dec 6, 2022 | Company News |
Roche has appointed Brad Moore as president and CEO of Roche Diagnostics North America, effective January 1, 2023.
Read MorePosted by Andy Lundin | Dec 2, 2022 | Hematology & Serology, Point-of-Care |
HemoSonics has received 510(k) market clearance from the U.S. FDA for the Quantra Hemostasis System with QStatCartridge.
Read More